How were (ASPX)'s earnings last quarter?

(ASPX) (NASDAQ:ASPX) announced its quarterly earnings data on Monday, March, 16th. The biopharmaceutical company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.59) by $0.15.

What other stocks do shareholders of (ASPX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ASPX) investors own include Achillion Pharmaceuticals (ACHN) , Alnylam Pharmaceuticals (ALNY) , GoPro (GPRO) , Ambarella (AMBA) , Alkermes (ALKS) , Align Technology (ALGN) , Akebia Therapeutics (AKBA) , Agios Pharmaceuticals (AGIO) , ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS) .

NASDAQ:ASPX

(ASPX) (ASPX) Stock Price, News & Analysis

→ A new way to collect income from stocks (From DTI) (Ad)

Free ASPX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 1.02 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (ASPX) alerts:

Ad Crypto Swap Profits

Claim Your Complimentary Bitcoin Reward

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

About (ASPX) Stock (NASDAQ:ASPX)

Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.

Ad Crypto Swap Profits

Claim Your Complimentary Bitcoin Reward

Secure Your Spot Now

ASPX Stock News Headlines

April 17, 2024 | msn.com

Guest Commentary | Why serving on civil grand jury benefits all

April 17, 2024 | msn.com

SPOTTED: Police release pictures of minivan connected to South Side business vandals

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

April 17, 2024 | msn.com

Audit of Oregon Department of Environmental Quality recommends better strategic planning

April 17, 2024 | msn.com

Butler County Auditor’s Office website sees ‘unusual activity’

April 17, 2024 | finance.yahoo.com

Westlake Announces First Quarter 2024 Earnings Conference Call

April 17, 2024 | msn.com

Earth Day activities happening in Oakland County

April 17, 2024 | finance.yahoo.com

Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

April 17, 2024 | seatrade-maritime.com

NTSB investigations in the spotlight with Dali bridge collision

April 17, 2024 | msn.com

Social housing tenants' anger over rats and leaks

April 16, 2024 | msn.com

Butler County auditor's website goes offline as security precaution

April 16, 2024 | msn.com

Pioneer Memorial Park grows into an arboretum

April 16, 2024 | msn.com

2024 Louisville homicides: Man dies after shooting in the Shively neighborhood

April 15, 2024 | msn.com

Wisconsin Allows Noncitizens to Get IDs to Vote?

April 15, 2024 | msn.com

More than Mediterranean: Exploring and acknowledging the benefits of diverse cultural and nutritional heritages

April 15, 2024 | baystreet.ca

Tesla to Announce Layoffs

April 15, 2024 | msn.com

Moderate vitamin E, C, and β-carotene intake reduces type 2 diabetes risk

April 14, 2024 | msn.com

Liverpool’s title chances suffer huge blow as Crystal Palace win at Anfield

April 14, 2024 | reuters.com

India's forex reserves rise for seventh consecutive week to record high

April 14, 2024 | msn.com

Oakland County community calendar April 14 and beyond

April 13, 2024 | msn.com

Mayo Clinic study offers insights into lucid episodes in dementia

April 13, 2024 | msn.com

Exercise boosts beneficial hormone transfer in breastfeeding mothers

April 12, 2024 | msn.com

Hospital sinks fuel antibiotic-resistant bacteria spread

April 12, 2024 | msn.com

Meta-analysis uncovers stress-responsive genes in Arabidopsis

April 12, 2024 | msn.com

Link between aldehydes and premature aging revealed

April 11, 2024 | msn.com

Storms in the Suncoast: Before you go, check your flight status right here!

See More Headlines

Receive ASPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ASPX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/16/2015
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:ASPX
CUSIP: N/A
CIK: 1454189
Web: N/A
Phone: +1-858-5582400
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

ASPX Stock Analysis - Frequently Asked Questions

How were (ASPX)'s earnings last quarter?: (ASPX) (NASDAQ:ASPX) announced its quarterly earnings data on Monday, March, 16th. The biopharmaceutical company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.59) by $0.15.
What other stocks do shareholders of (ASPX) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (ASPX) investors own include Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), GoPro (GPRO), Ambarella (AMBA), Alkermes (ALKS), Align Technology (ALGN), Akebia Therapeutics (AKBA), Agios Pharmaceuticals (AGIO), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS).

This page (NASDAQ:ASPX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(ASPX) (ASPX) Stock Price, News & Analysis

About (ASPX) Stock (NASDAQ:ASPX)

ASPX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

ASPX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info